Løvig T, Meling G I, Diep C B, Thorstensen L, Norheim Andersen S, Lothe R A, Rognum T O
Institute of Forensic Medicine, The National Hospital, University of Oslo, Norway.
Scand J Gastroenterol. 2002 Oct;37(10):1184-93. doi: 10.1080/003655202760373407.
Adenomatous polyposis coli (APC) and beta-catenin (encoded by CTNNB1) are important components in the WNT signalling pathway, a pathway altered in nearly all colorectal tumours. Conflicting results are reported on whether APC mutations are less common in tumours with a high degree of microsatellite instability (MSI-H) than in microsatellite stable (MSS) ones, and whether mutations in the regulatory domain of CTNNB1 substitute for APC mutations in the MSI-H tumours.
A consecutive series of 218 primary colorectal carcinomas, stratified by MSI status, were analysed for mutations in the APC gene (by the protein truncation test) and in the CTNNB1 gene (by single-strand conformation polymorphism).
APC mutations detected in 66% of the patients were significantly more frequent in the MSS and MSI-L (low) tumours than in the MSI-H tumour group (P < 0.001). The MSI-H tumours tended to have more frameshift mutations than the MSS/MSI-L tumours. The majority of the APC mutations were located in the mutation cluster region (MCR). Patients that had lost all beta-catenin binding sites of the APC gene showed a shorter survival time than patients who retained some or all of these binding sites (P = 0.045). Two mutations were found in the CTNNB1 gene, but neither of them was located in the regulatory domain in exon 3.
This study confirms that APC mutations are less frequent in MSI-H tumours than in MSS and MSI-L tumours. However, CTNNB1 mutations do not substitute for APC mutations in MSI-H tumours in these Norwegian patients.
腺瘤性息肉病 coli(APC)和β-连环蛋白(由 CTNNB1 编码)是 WNT 信号通路的重要组成部分,该通路在几乎所有结直肠癌中均发生改变。关于 APC 突变在高度微卫星不稳定(MSI-H)肿瘤中是否比在微卫星稳定(MSS)肿瘤中更少见,以及 CTNNB1 调节域中的突变是否可替代 MSI-H 肿瘤中的 APC 突变,报道结果相互矛盾。
对连续的 218 例原发性结直肠癌按 MSI 状态分层,分析 APC 基因(通过蛋白质截短试验)和 CTNNB1 基因(通过单链构象多态性)的突变情况。
在 66%的患者中检测到的 APC 突变在 MSS 和 MSI-L(低)肿瘤中比在 MSI-H 肿瘤组中显著更常见(P < 0.001)。MSI-H 肿瘤比 MSS/MSI-L 肿瘤倾向于有更多的移码突变。大多数 APC 突变位于突变簇区域(MCR)。失去 APC 基因所有β-连环蛋白结合位点的患者比保留部分或全部这些结合位点的患者生存时间更短(P = 0.045)。在 CTNNB1 基因中发现了两个突变,但均不在外显子 3 的调节域中。
本研究证实 APC 突变在 MSI-H 肿瘤中比在 MSS 和 MSI-L 肿瘤中更少见。然而,在这些挪威患者中,CTNNB1 突变不能替代 MSI-H 肿瘤中的 APC 突变。